انجمن بیوکن | BioCan

انجمن بیوکن | BioCan

انجمن بیوکن | BioCan Telegram | DID YOU KNOW?

At its heart, Telegram is little more than a messaging app like WhatsApp or Signal. But it also offers open channels that enable a single user, or a group of users, to communicate with large numbers in a method similar to a Twitter account. This has proven to be both a blessing and a curse for Telegram and its users, since these channels can be used for both good and ill. Right now, as Wired reports, the app is a key way for Ukrainians to receive updates from the government during the invasion. Ukrainian President Volodymyr Zelensky said in a video message on Tuesday that Ukrainian forces "destroy the invaders wherever we can." At the start of 2018, the company attempted to launch an Initial Coin Offering (ICO) which would enable it to enable payments (and earn the cash that comes from doing so). The initial signals were promising, especially given Telegram’s user base is already fairly crypto-savvy. It raised an initial tranche of cash – worth more than a billion dollars – to help develop the coin before opening sales to the public. Unfortunately, third-party sales of coins bought in those initial fundraising rounds raised the ire of the SEC, which brought the hammer down on the whole operation. In 2020, officials ordered Telegram to pay a fine of $18.5 million and hand back much of the cash that it had raised. The fake Zelenskiy account reached 20,000 followers on Telegram before it was shut down, a remedial action that experts say is all too rare. On December 23rd, 2020, Pavel Durov posted to his channel that the company would need to start generating revenue. In early 2021, he added that any advertising on the platform would not use user data for targeting, and that it would be focused on “large one-to-many channels.” He pledged that ads would be “non-intrusive” and that most users would simply not notice any change.
انجمن بیوکن | BioCan from es

انجمن بیوکن | BioCan💠 انجمن BioCan 💠

بیولوژی و سرطان

🔹زیر نظر معاونت دانشجویی و مرکز پژوهش های علمی دانشجویان دانشگاه علوم پزشکی تهران

🔹تفاهم نامه با مرکز تحقیقات بیولوژی سرطان بیمارستان امام خمینی (ره)

@Ssoleimanid

🟪 Instagram:@biocantums

Open Telegram